AKRO - Akero Therapeutics announces pricing of stock offering to raise $319M
2024-03-06 03:34:48 ET
More on Akero Therapeutics
- Akero: Phase 2b NASH Data Bodes Well For Phase 3 SYNCHRONY Program
- Akero stock jumps as lead drug shows added fibrosis improvement in MASH patients
- Eli Lilly hurts NASH drug developers after mid-stage win for obesity therapy
- Seeking Alpha’s Quant Rating on Akero Therapeutics
- Historical earnings data for Akero Therapeutics